This study is the first to report that caffeine ameliorates NASH by inhibiting NLRP3 inflammasome activation through the suppression of the TLR4/MAPK/NF-κB signaling pathway. This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatohepatitis.